论文部分内容阅读
目的 总结分析肝段或亚肝段动脉化疗栓塞治疗原发性肝癌的效果。方法 34例原发性肝癌行肝段或亚肝段动脉化疗栓塞术。采用 4F导管或 3F同轴导管插至肿瘤供血的段或亚段动脉 ,灌注化疗药物 ,碘油药物乳剂及明胶海绵栓塞。结果 平均生存期 18个月 ,1、2、3、4年的生存率分别为 70 .6 %、32 .4%、11.8%、5 .9%。 6例伴门静脉瘤栓的病人中有 4例治疗后瘤栓消失。结论 肝段或亚肝段动脉化疗栓塞是治疗病灶局限于段或亚段肝癌的好方法 ,而且对门静脉瘤栓的治疗效果好。
Objective To summarize and analyze the effect of hepatic or sub-hepatic artery chemoembolization in the treatment of primary liver cancer. Methods 34 cases of primary liver cancer underwent hepatic segmental artery or hepatic artery chemoembolization. 4F catheter or 3F coaxial catheter inserted into the tumor blood supply section or sub-artery, chemotherapy drugs, lipiodol emulsion and gelatin sponge embolization. Results The average survival time was 18 months. The survival rates at 1, 2, 3 and 4 years were 70.6%, 32.4%, 11.8% and 5.9% respectively. Of the 6 patients with portal vein thrombosis, 4 had tumor thrombus disappeared after treatment. Conclusion The hepatic or sub-hepatic artery chemoembolization is a good way to treat the lesion limited to the segment or sub-segment of liver cancer, and it is effective in treating portal vein embolism.